Name: What should patients do if their doctor is unsure if they have smoldering or active myeloma?
Uploaded: 2018-03-01T10:03:10-0800
Duration: 3 min 52 s
Description: In this week’s video, Dr. Brian G.M. Durie emphasizes the importance of correctly diagnosing and staging myeloma before beginning treatment for the disease. BOTTOM LINE: Seek out a myeloma expert to ensure you only begin treatment when absolutely necessary and monitor closely for a definitive diagnosis.

In this week’s video, Dr. Brian G.M. Durie emphasizes the importance of correctly diagnosing and staging myeloma before beginning treatment for the disease.

BOTTOM LINE:
Seek out a myeloma expert to ensure you only begin treatment when absolutely necessary and monitor closely for a definitive diagnosis.

If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].

To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].

Image of Dr. Brian G.M. Durie Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.

Analysis of treatment efficacy in the GEM-CESAR trial for high-risk smoldering multiple myeloma patients

Is D-Rd effective in non-transplant eligible patients.

Is D-Rd an effective treatment for older, non-transplant eligible myeloma patients?

What are the options for a myeloma patient who has relapsed on a two-drug combination?

What supplements, if any, should a myeloma patient take?

Share On

Donation

What should patients do if their doctor is unsure if they have smoldering or active myeloma?

Analysis of treatment efficacy in the GEM-CESAR trial for high-risk smoldering multiple myeloma patients

Is D-Rd an effective treatment for older, non-transplant eligible myeloma patients?

Give Where Most Needed